Simultaneous multi-element imaging using NanoSIMS (nanoscale secondary ion mass spectrometry), exploiting the novel combination of 195 
Understanding the subcellular distribution of metal-based anticancer drugs provides key insights in identifying their organelle and molecular targets. Platinum-based 15 chemotherapeutics have been the subject of intense investigation for decades due to the clinical success of cisplatin (Chart 1). 1 There have been numerous studies reporting the tagging of Pt complexes with fluorescent moieties to allow their intracellular distribution to be mapped using fluorescence microscopy, 2, 3 as 20 well as various reports on the direct mapping of Pt inside tumour cells by using either synchrotron techniques 4 or electron microscopic methods. 5 Herein we report on the novel use of simultaneous direct multi-element imaging by nano-scale secondary ion mass spectrometry (NanoSIMS) to monitor 25 tracking and distribution of 15 N-labelled Pt antitumour agents within cells. The results confirm the nucleolus as target of highlycharged polynuclear platinum drugs (PPCs), consistent with previous suggestions, 3 and show distinct differences in processing compared to the mononuclear agents. Significant advances have been made in visualising cellular distribution of metal-based therapeutics through the application of highly sensitive surface analysis techniques such as secondary ion mass spectrometry (SIMS), to cellular imaging. 7 SIMS has been used to study cisplatin-induced alterations in intracellular 35 chemical composition in an established model (LLC-PK(1) cells) for studying renal injury.
8 Nano-scale secondary ion mass spectrometry, a recent development in SIMS instrumentation, combines exquisite spatial resolution (50 nm),
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Chart 1 Structures of platinum antitumour compounds. Fully 15 N-labelled cisplatin and TriplatinNC were used in this study. In NanoSIMS, a high-energy ion beam (Cs + ) is rastered across the sample surface, sputtering atoms from the topmost monolayers and generating negative secondary ions. The secondary ions are sorted according to their mass, producing a map of the sample 55 surface showing the distribution of the selected ion species. Furthermore, the high mass resolution of NanoSIMS allows the simultaneous detection of multiple isotopes of the same element (e.g 15 N/ 14 N). 9 We have previously reported the use of NanoSIMS to detect Au inside tumour cells following treatment 5 with an antitumour Au(I) phosphine complex, resulting in the identification of molecular targets not previously considered. 10 In this communication, we extend this technique to the dual imaging of both 15 of the 15 N/ 14 N ratio is represented on a colour scale, and the intensity is an index of the statistical reliability. 9 The HSI image in Fig. 1 clearly shows enrichment of 15 N around the margin of the cell, and 'hotspots' in the cytoplasm (visible as pink).
The cellular accumulation of TriplatinNC (20 µM) was also 35 examined after 2 h treatment. Significant accumulation of both 195 Pt -and 15 N was observed; secondary ion images for two cells are shown in Fig. 2 (and Fig. S4 , ESI †). In this case the Pt is located in the vesicle-like structures, and there is significant accumulation in the cytoplasm, reflecting greater accumulation 40 with time. Notably, the HSI image shows 15 N enrichment in the nucleolus (grey arrow), at the exclusion of the nucleus. Similar to the cells treated with TriplatinNC for 1 h (Fig. 1), The 15 N enrichment was determined for whole cells and the HCT116 cells after 4 h, where the fluorescence originating from the conjugate was localised to the nucleolus and cytoplasm of the cells, with the exclusion of nuclear accumulation.
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The previous application of [ 1 H, 15 N] HSQC NMR methods has afforded significant insights into the hydrolysis and kinetics 5 of DNA adduct formation of Pt drugs. 12 In a novel extension of this isotopic labelling technique, we have shown that multielement mapping of Pt-am(m)ine antitumour drugs by NanoSIMS provides a significant contribution to metal-based therapeutics imaging, given that the drugs can be studied in absence of 10 fluorescent labels, which can potentially influence pharmacokinetics of the "parent" structure. Moreover, localisation to specific organelles can be studied without the need for colocalisation studies employing specific markers, such as Fibrillarin as a nucleolar marker. 
